Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
14 Février 2025 - 2:15AM
Edgar (US Regulatory)
Exhibit A
JOINT FILING AGREEMENT
The undersigned agree that
this Schedule 13G Amendment No. 4 dated February 13, 2025 relating to the Common Stock, par value $0.0001 per share, of Kura Oncology,
Inc. shall be filed on behalf of the undersigned.
|
SUVRETTA CAPITAL MANAGEMENT, LLC
By: /s/ Aaron Cowen |
|
Name: Aaron Cowen |
|
Title: Authorized Signatory |
|
AVERILL MASTER FUND, LTD.
By: /s/ Aaron Cowen |
|
Name: Aaron Cowen |
|
Title: Director |
|
AARON COWEN
By: /s/ Aaron Cowen |
Exhibit B
CONTROL PERSON IDENTIFICATION
Suvretta Capital Management, LLC is the relevant entity for which
Aaron Cowen is the control person.
Kura Oncology (NASDAQ:KURA)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
Kura Oncology (NASDAQ:KURA)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025